Overview Fundamentals API Earnings EOD API Sample Code Pricing

Chimerix Inc (CMRX NASDAQ) stock market data APIs

$0.94 0.04(4.4%) as of July 19, 2024
Price chart is built with Anychart

Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline products include ONC201 a program that is in Phase 3 clinical trial for treating patients with H3 K27M-mutant diffuse glioma, as well as in Phase 2 clinical trial for the treatment of rare neuroendocrine tumors; and ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist, which is in Phase 1 clinical trial for adult and pediatric patients with primary central nervous system tumors. The company also develops ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for oncology indications; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of SARS-CoV-2. It has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Chimerix Inc Financial Data Overview

80 667 K
89 630 K
41 000
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CMRX',
Type: 'Common Stock',
Name: 'Chimerix Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000R33651',
CIK: '1117480',
EmployerIdNumber: '33-0903395',
FiscalYearEnd: 'December',
IPODate: '2013-04-11',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Chimerix Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 41 000
  • EBITDA -95 146 000
  • Earnings Per Share -0.94
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Chimerix Inc Earnings via APIs

  • Latest Release 2024-05-01
  • EPS/Forecast -0.22

Get Chimerix Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?